Big-money moves in the US on 25/06/30 (Mon)

Insider buys: 103 trades
Insider sales: 411 trades
Congress trades: 0 trades

Notable trades of the day

No trade stood out on this day.

Trades disclosed this day

Michael S. Dell10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$11.5M
465,063 sh
$11.5M
Filed 25/06/30
Traded 25/06/26
RA Capital Healthcare FundDirector
BuyCidara Therapeutics
Buy
Cidara Therapeutics
CDTX
$100M
2,272,727 sh
$100M
Filed 25/06/30
Traded 25/06/26
Peter KolchinskyDirector
BuyCidara Therapeutics
Buy
Cidara Therapeutics
CDTX
$100M
2,272,727 sh
$100M
Filed 25/06/30
Traded 25/06/26
Ra Capital ManagementDirector
BuyCidara Therapeutics
Buy
Cidara Therapeutics
CDTX
$100M
2,272,727 sh
$100M
Filed 25/06/30
Traded 25/06/26
Rajeev M. ShahDirector
BuyCidara Therapeutics
Buy
Cidara Therapeutics
CDTX
$100M
2,272,727 sh
$100M
Filed 25/06/30
Traded 25/06/26
Julian BakerDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$26.4M
600,309 sh
$26.4M
Filed 25/06/30
Traded 25/06/30
667Director
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$26.4M
600,309 sh
$26.4M
Filed 25/06/30
Traded 25/06/30
Baker Bros. AdvisorsDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$26.4M
600,309 sh
$26.4M
Filed 25/06/30
Traded 25/06/30
Felix BakerDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$26.4M
600,309 sh
$26.4M
Filed 25/06/30
Traded 25/06/30
Baker Brothers Life SciencesDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$26.4M
600,309 sh
$26.4M
Filed 25/06/30
Traded 25/06/30
Baker Bros. AdvisorsDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$26.4M
600,309 sh
$26.4M
Filed 25/06/30
Traded 25/06/30
Liberty Mutual Holding10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$11.6M
468,813 sh
$11.6M
Filed 25/06/30
Traded 25/06/26
Mutual Insurance Co Liberty10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$11.6M
468,813 sh
$11.6M
Filed 25/06/30
Traded 25/06/26
Noble Environmental Investments10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$11.5M
465,063 sh
$11.5M
Filed 25/06/30
Traded 25/06/26
MSD Capital10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$11.5M
465,063 sh
$11.5M
Filed 25/06/30
Traded 25/06/26
MSD Portfolio L.P. - Investments10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$11.5M
465,063 sh
$11.5M
Filed 25/06/30
Traded 25/06/26
Liberty Mutual Holding10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$7.7M
312,542 sh
$7.7M
Filed 25/06/30
Traded 25/06/26
Mutual Insurance Co Liberty10% Owner
Buy5C Lending Partners
Buy
5C Lending Partners
$7.7M
312,542 sh
$7.7M
Filed 25/06/30
Traded 25/06/26
STM Partners10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Liberty Capital10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Liberty 77 Capital Partners10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Liberty 77 Fund10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Liberty 77 Capital10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Steven T. Mnuchin10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Liberty 77 Fund International10% Owner
BuyLionsgate Studios
Buy
Lionsgate Studios
LION
$457.9K
79,766 sh
$457.9K
Filed 25/06/30
Traded 25/06/26
Baker Bros. AdvisorsDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$2.4M
55,191 sh
$2.4M
Filed 25/06/30
Traded 25/06/30
Felix BakerDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$2.4M
55,191 sh
$2.4M
Filed 25/06/30
Traded 25/06/30
667Director
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$2.4M
55,191 sh
$2.4M
Filed 25/06/30
Traded 25/06/30
Julian BakerDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$2.4M
55,191 sh
$2.4M
Filed 25/06/30
Traded 25/06/30
Baker Brothers Life SciencesDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$2.4M
55,191 sh
$2.4M
Filed 25/06/30
Traded 25/06/30
Baker Bros. AdvisorsDirector
BuyKymera Therapeutics
Buy
Kymera Therapeutics
KYMR
$2.4M
55,191 sh
$2.4M
Filed 25/06/30
Traded 25/06/30
Jen Hsun HuangPresident and CEO
Planned sale10b5-1 planNvidia
Planned sale10b5-1 plan
Nvidia
NVDA
$11.8M
75,000 sh
$11.8M
Filed 25/06/30
Traded 25/06/30
Bios Clinical Opportunity FundDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
BP DirectorsDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Equity COFDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios 2024 Co-InvestDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Equity PartnersDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund IIDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund I QPDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Leslie W. KreisDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Cavu AdvisorsDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Cavu ManagementDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund IDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund II QPDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Equity Partners IIDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund II NTDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Equity Partners IIIDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Actuate Co-Invest IIDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Advisors GPDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27
Bios Fund III NTDirector
BuyActuate Therapeutics
Buy
Actuate Therapeutics
ACTU
$500K
71,428 sh
$500K
Filed 25/06/30
Traded 25/06/27